FROM 24TH JANUARY.
negotiations brought forward with new tier 1 partners New immunoassay technology platform to accelerate PromarkerD rollout in US Clinical samples for first phase of CDx collaborative study received from Janssen Research & Development, LLC Key Opinion Leader (KOL) engagement to drive US demand for PromarkerD
Ann: PromarkerD US market update, page-37
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
86.0¢ |
Change
0.030(3.61%) |
Mkt cap ! $112.6M | |||
| Open | High | Low | Value | Volume |
| 83.0¢ | 86.0¢ | 83.0¢ | $123.2K | 145.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 26055 | 84.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.0¢ | 2893 | 1 |
View Market Depth
| Last trade - 15.58pm 06/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |